Big blow: India revokes GSK cancer drug patent

India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that......

FDI reforms: Now, pharma in focus

A day after a high-level panel headed by Prime Minister Manmohan Singh relaxed foreign direct investment (FDI) norms in sectors ranging from telecom to single brand retail, it seems he would hold a......

Markets end choppy session on a flat note

After a choppy session, the markets closed on a flat note, weighed down by selling in oil & gas and IT counters. The Sensex closed down 14 points at 18,731 while the Nifty closed unchanged at......

Stocks of MNCs with high promoter stake lose steam

Stock investors are turning averse to one of the most popular investment themes on Dalal Street in the past year or so. The recent rally in the shares of multinational companies (MNCs) with......